SB 433

  • Georgia Senate Bill
  • 2019-2020 Regular Session
  • Introduced in Senate
  • Senate
  • House
  • Governor

'Diabetes Drug Pricing Transparency Act of 2020'; disclosure of diabetes prescription drug pricing; require

Abstract

A BILL to be entitled an Act to amend Title 33 of the Official Code of Georgia Annotated, relating to insurance, so as to require disclosure of diabetes prescription drug pricing; to provide for a short title; to provide for legislative findings; to provide for definitions; to provide for a listing of diabetes prescription drugs; to provide for drug manufacturer and pharmacy benefits manager report forms and insurer pricing reports; to provide for certain other reports; to provide for penalties; to amend Chapter 1 of Title 10 of the Official Code of Georgia Annotated, relating to selling and other trade practices, so as to provide for penalties regarding unfair or deceptive practices in consumer transactions; to provide for related matters; to provide for an effective date and applicability; to repeal conflicting laws; and for other purposes.

Bill Sponsors (5)

Votes


No votes to display

Actions


Feb 25, 2020

Senate

Senate Read and Referred

  • Referral-Committee
Insurance and Labor

Feb 24, 2020

Senate

Senate Hopper

Bill Text

Bill Text Versions Format
As introduced LC 46 0271 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Georgia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.